BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Limaye AP, Babu TM, Boeckh M. Progress and Challenges in the Prevention, Diagnosis, and Management of Cytomegalovirus Infection in Transplantation. Clin Microbiol Rev 2020;34:e00043-19. [PMID: 33115722 DOI: 10.1128/CMR.00043-19] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Chou S, Watters M, Sinha R, Kleiboeker S. Ganciclovir and maribavir susceptibility phenotypes of cytomegalovirus UL97 ATP binding region mutations detected by expanded genotypic testing. Antiviral Res 2021;193:105139. [PMID: 34273445 DOI: 10.1016/j.antiviral.2021.105139] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Xu CQ, Chen XL, Zhang DS, Wang JW, Yuan H, Chen WF, Xia H, Zhang ZY, Peng FH. Diagnosis of cytomegalovirus encephalitis using metagenomic next-generation sequencing of blood and cerebrospinal fluid: A case report. World J Clin Cases 2022; 10(14): 4601-4607 [DOI: 10.12998/wjcc.v10.i14.4601] [Reference Citation Analysis]
3 Struble EB, Murata H, Komatsu T, Scott D. Immune Prophylaxis and Therapy for Human Cytomegalovirus Infection. Int J Mol Sci 2021;22:8728. [PMID: 34445434 DOI: 10.3390/ijms22168728] [Reference Citation Analysis]
4 Mavri M, Spiess K, Rosenkilde MM, Rutland CS, Vrecl M, Kubale V. Methods for Studying Endocytotic Pathways of Herpesvirus Encoded G Protein-Coupled Receptors. Molecules 2020;25:E5710. [PMID: 33287269 DOI: 10.3390/molecules25235710] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Lee SY, Ko DH, Son MJ, Kim JA, Jung K, Kim YS. Affinity Maturation of a T-Cell Receptor-Like Antibody Specific for a Cytomegalovirus pp65-Derived Peptide Presented by HLA-A*02:01. Int J Mol Sci 2021;22:2349. [PMID: 33652936 DOI: 10.3390/ijms22052349] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Barten MJ, Baldanti F, Staus A, Hüber CM, Glynou K, Zuckermann A. Effectiveness of Prophylactic Human Cytomegalovirus Hyperimmunoglobulin in Preventing Cytomegalovirus Infection following Transplantation: A Systematic Review and Meta-Analysis. Life 2022;12:361. [DOI: 10.3390/life12030361] [Reference Citation Analysis]
7 Luciani L, Mongin D, Ninove L, Nougairède A, Bardy K, Gazin C, Charrel RN, Zandotti C. Cytomegalovirus Viral Load in Transplanted Patients Using the NeuMoDx™ (Qiagen) Automated System: A 1-Month Experience Feedback. Viruses 2021;13:1619. [PMID: 34452483 DOI: 10.3390/v13081619] [Reference Citation Analysis]
8 He T, Edwards TC, Xie J, Aihara H, Geraghty RJ, Wang Z. 4,5-Dihydroxypyrimidine Methyl Carboxylates, Carboxylic Acids, and Carboxamides as Inhibitors of Human Cytomegalovirus pUL89 Endonuclease. J Med Chem 2022. [PMID: 35377638 DOI: 10.1021/acs.jmedchem.2c00203] [Reference Citation Analysis]